An international research team has made significant strides in protein design, successfully creating large-scale structures that emulate the self-assembly of natural viruses through artificial intelligence.
This innovative approach, spearheaded by a Korean scientist, leverages AI technology to replicate complex biological processes, which could have profound implications for medical applications.
The potential uses for these AI-designed proteins include enhancing the effectiveness of vaccines and improving drug delivery systems, marking a notable advancement in biotechnology.